US-based CBD Life Sciences is introducing its new “Mushroom Madness” supplement, infused with extracts from Reishi mushroom, Lion’s Mane, and ashwagandha root. Designed for stress reduction and support of brain and immune health, the product is expected to increase the company’s revenue by 20% within its first year. President and CEO Lisa Nelson emphasizes the growing demand for natural health solutions, calling the supplement a potential “game-changer.” The product blends Reishi for immune enhancement and tumor growth inhibition, Lion’s Mane for cognitive support and nerve regeneration, and ashwagandha for stress reduction and inflammation control. While some skepticism surrounds the health claims of these ingredients, ongoing research supports their potential benefits.
